Zinc phosphate

We are Zinc phosphate CAS:7779-90-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
sicorznp/m
zpf
j0852
delaphos
lf-pw2
delaphos2m
sicorznp/s
zp-sb
virchem931
 
Molecular Formula:  O8P2Zn3
Molecular Weight: 386.08300

Appearance and properties: white powder
Density: 3.99
Boiling point: 158ºC at 760 mmHg
Melting point: 900°C
Refractive index: 1.595
 
Stability: Stable at normal temperatures and pressures.
Storage conditions: Keep tightly closed.
Uses: Used as adhesives for medicine and dentistry, as well as anti-rust paints, phosphors, etc.

Items of Analysis Standard of Analysis Test Results
Whiteness 85-93% 89%
Zinc phosphate ≥45% 46.3%
PO4 20-30% 25.4%
Moisture ≤1.5% 1.0%
PH Value 5.5-7.5 6.3%
Residue on sieve(45um) ≤0.5%  0.3%
Oil absorption g/100g 25-35% 30%
Average particle size(D50) ≤6 um 5.04 um
Conclusion Conforms to Factory Standard
 

 

Zinc phosphate


Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.3-hydroxy-2-((3-hydroxy-2,2-bis(hydroxymethyl)propoxy)methyl)-2-(hydroxymethyl)propyl benzoate The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city.N-[2-(3,4,5-Trimethoxy-benzyl)-pent-4-enyl]-benzamide Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.64248-63-1 Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.

Related Products
Product Name
Dibenzothiophene-2-Boronic Acid View Details
1-Naphthylamine View Details
Light Stabilizer 2908 View Details
N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide manufacturer Iminodiacetic acid manufacturer 2-Chloro-4,6-dimethoxypyrimidine manufacturer 4-Dibenzothienylboronic acid manufacturer N-cyclohexyl-N’-(2-(4-morpholinyl)ethyl)carbodiimide manufacturer